Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation

Published:2013-03-18 Issue:8 Volume:37 Page:840-842
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Indriolo A.¹,Fagiuoli S.²,Pasulo L.²,Fiorino G.³,Danese S.¹,Ravelli P.¹

Affiliation:

1. Gastroenterology and Digestive Unit; Ospedali Riuniti di Bergamo; Bergamo; Italy

2. Gastroenterology and Hepatology of Transplantation Unit; Ospedali Riuniti di Bergamo; Bergamo; Italy

3. IBD Center; Gastroenterology Unit; Humanitas Clinic Institute; Rozzano; Italy

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12256/fullpdf

Reference5 articles.

1. The safety and efficacy of antitumor necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series;Sandhu;Aliment Pharmacol Ther,2012

2. Anti-tumor necrosis factor treatment of inflammatory bowel disease in liver transplant recipients;Mohabbat;Aliment Pharmacol Ther,2012

3. Infliximab for ulcerative colitis following liver transplatation;Lal;Eur J Gastroenterol Hepatol,2007

4. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation;El-Nachef;Am J Gastroenterol,2010

5. Infliximab in patients with ulcerative colitis and primary sclerosing cholangitis before and after liver transplantation;Indriolo;JCC,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant;Journal of Clinical Gastroenterology;2024-08-14

2. Safety of biologic treatments in solid organ transplant recipients: A systematic review;Seminars in Arthritis and Rheumatism;2021-12

3. Safety of Combination Biologic and Antirejection Therapy Post–Liver Transplantation in Patients With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2019-10-28

4. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series;Digestive and Liver Disease;2018-07

5. Efficacy and Safety of Anti–TNF-α Agents in Inflammatory Bowel Disease After Liver Transplant: A Case Series;Transplantation Proceedings;2018-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3